Jiang et al., showed that VEGF-C expression is associated with poor prognosis for NSCLC patients, but not with clinical outcomes for patients with lung adenocarcinoma, via meta-analysis of 1988 patients aggregated from 16 trials [56]. The gene discussed is VEGFC; the disease is lung adenocarcinoma.